Ion channel architecture of the renal microcirculation

Current Hypertension Reviews

Volumn 2, Issue 1, 2006, Pages 69-81

  Turner, Malcolm R ^a   Pallone, Thomas L ^b  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Calcium; Chloride; Hypertension; Ion channel; Kidney; Potassium

Indexed keywords

1 (2 HYDROXY 5 TRIFLUOROMETHYLPHENYL) 5 TRIFLUOROMETHYL 2(3H) BENZIMIDAZOLONE; 1 [2 (4 METHOXYPHENYL) 2 [3 (4 METHOXYPHENYL)PROPOXY]ETHYL] 1H IMIDAZOLE; 18ALPHA GLYCYRRHETINIC ACID; 20 HYDROXYICOSATETRAENOIC ACID; 4 (2 BENZYLBENZOYL) 2,5 DIMETHYL 1H PYRROLE 3 CARBOXYLIC ACID METHYL ESTER; ACETYLCHOLINE; ANGIOTENSIN II; APAMIN; ARACHIDONIC ACID; BRADYKININ; CALCISEPTINE; CALCIUM ION; CHARYBDOTOXIN; CHLORIDE ION; CYTOCHROME P450; DILTIAZEM; ENDOTHELIN; GAP JUNCTION PROTEIN; GLIBENCLAMIDE; ION CHANNEL; MIBEFRADIL; NIFEDIPINE; NILVADIPINE; NITRIC OXIDE; PIMOZIDE; POTASSIUM CHANNEL; VASODILATOR AGENT; VASOPRESSIN; VOLTAGE GATED CALCIUM CHANNEL;

ARTERIOLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CALCIUM TRANSPORT; CELL MEMBRANE DEPOLARIZATION; CELL MEMBRANE POTENTIAL; CHLORIDE CONDUCTANCE; CONCENTRATION (PARAMETERS); CYTOPLASM; ENZYME INHIBITION; EXTRACELLULAR SPACE; GLOMERULUS; HUMAN; HYPERPOLARIZATION; HYPERTENSION; ION CONDUCTANCE; JUXTAGLOMERULAR APPARATUS; KIDNEY CIRCULATION; KIDNEY CORTEX; MICROCIRCULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; REVIEW; SMOOTH MUSCLE FIBER;

EID: 33746167358     PISSN: 15734021     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340206775473685     Document Type: Review

References (172)

1. Bankir L, de Rouffignac C. Urinary concentrating ability: insights from comparative anatomy. Am J Physiol 1985; 249: R643-R666.
2. Kriz W. Structural organization of the renal medulla: comparative and functional aspects. Am J Physiol 1981; 241: R3-16.
3. Lemley KV, Kriz W. Cycles and separations: the histotopography of the urinary concentrating process. Kidney Int 1987; 31: 538-48.
4. Pallone TL, Turner MR, Edwards A, et al. Countercurrent exchange in the renal medulla. Am J Physiol Regul Integr Comp Physiol 2003; 284: R1153-R1175.
5. Hansen PB, Jensen BL, Andreasen D, et al. Vascular smooth muscle cells express the alpha(1A) subunit of a P-/Q-type voltage-dependent Ca(2+)Channel, and It is functionally important in renal afferent arterioles. Circ Res 2000; 87: 896-902.
6. Hansen PB, Jensen BL, Andreasen D, et al. Differential expression of T- and L-type voltage-dependent calcium channels in renal resistance vessels. Circ Res 2001; 89: 630-8.
7. Jensen BL, Friis UG, Hansen PB, et al. Voltage-dependent calcium channels in the renal microcirculation. Nephrol Dial Transplant 2004; 19: 1368-73.
8. Ozawa Y, Hayashi K, Nagahama T, et al. Renal afferent and efferent arteriolar dilation by nilvadipine: studies in the isolated perfused hydronephrotic kidney. J Cardiovasc Pharmacol 1999; 33: 243-7.
9. Ozawa Y, Hayashi K, Nagahama T, et al. Effect of T-type selective calcium antagonist on renal microcirculation: studies in the isolated perfused hydronephrotic kidney. Hypertension 2001; 38: 343-7.
10. Salomonsson M, Sorensen CM, Arendshorst WJ, et al. Calcium handling in afferent arterioles. Acta Physiol Scand 2004; 181: 421-9.
11. Carmines PK, Morrison TK, Navar LG. Angiotensin II effects on microvascular diameters of in vitro blood-perfused juxtamedullary nephrons. Am J Physiol 1986; 251: F610-F618.
12. Loutzenhiser R, Hayashi K, Epstein M. Divergent effects of KCl-induced depolarization on afferent and efferent arterioles. Am J Physiol 1989; 257: F561-F564.
13. Conger JD, Falk SA. KCl and angiotensin responses in isolated rat renal arterioles: effects of diltiazem and low-calcium medium. Am J Physiol 1993; 264: F134-F140.
14. Inscho EW, Mason MJ, Schroeder AC, et al. Agonist-induced calcium regulation in freshly isolated renal microvascular smooth muscle cells. J Am Soc Nephrol 1997; 8: 569-79.
15. Loutzenhiser R, Chilton L, Trottier G. Membrane potential measurements in renal afferent and efferent arterioles: actions of angiotensin II. Am J Physiol 1997; 273: F307-F314.
16. Arendshorst WJ, Brannstrom K, Ruan X. Actions of angiotensin II on the renal microvasculature. J Am Soc Nephrol 1999; 10 Suppl 11: S149-S161.
17. Helou CM, Marchetti J. Morphological heterogeneity of renal glomerular arterioles and distinct [Ca2+]i responses to ANG II. Am J Physiol 1997; 273: F84-F96.
18. Inscho EW, Schroeder AC, Deichmann PC, et al. ATP-mediated Ca2+ signaling in preglomerular smooth muscle cells. Am J Physiol 1999; 276: F450-F456.
19. Iversen BM, Arendshorst WJ. ANG II and vasopressin stimulate calcium entry in dispersed smooth muscle cells of preglomerular arterioles. Am J Physiol 1998; 274: F498-F508.
20. Loutzenhiser K, Loutzenhiser R. Angiotensin II-induced Ca(2+) influx in renal afferent and efferent arterioles: differing roles of voltage-gated and store-operated Ca(2+) entry. Circ Res 2000; 87: 551-7.
21. Carmines PK, Navar LG. Disparate effects of Ca channel blockade on afferent and efferent arteriolar responses to ANG II. Am J Physiol 1989; 256: F1015-F1020.
22. Fleming JT, Parekh N, Steinhausen M. Calcium antagonists preferentially dilate preglomerular vessels of hydronephrotic kidney. Am J Physiol 1987; 253: F1157-F1163.
23. Loutzenhiser RD, Epstein M, Fischetti F, et al. Effects of amlodipine on renal hemodynamics. Am J Cardiol 1989; 64: 1221-71.
24. Loutzenhiser R, Epstein M, Horton C. Inhibition by diltiazem of pressure-induced afferent vasoconstriction in the isolated perfused rat kidney. Am J Cardiol 1987; 59: 72A-5A.
25. Navar LG, Inscho EW, Imig JD, et al. Heterogeneous activation mechanisms in the renal microvasculature. Kidney Int Suppl 1998; 67: S17-S21.
26. Takenaka T, Ohno Y, Hayashi K, et al. Governance of arteriolar oscillation by ryanodine receptors. Am J Physiol Regul Integr Comp Physiol 2003; 285: R125-R131.
27. Rhinehart K, Zhang Z, Pallone TL. Ca(2+) signaling and membrane potential in descending vasa recta pericytes and endothelia. Am J Physiol Renal Physiol 2002; 283: F852-F860.
28. Zhang Z, Rhinehart K, Pallone TL. Membrane potential controls calcium entry into descending vasa recta pericytes. Am J Physiol Regul Integr Comp Physiol 2002; 283: R949-R957.
29. Zhang Z, Cao C, Lee-Kwon W, et al. Descending vasa recta pericytes express a voltage operated Na+ conductance. J Physiol 2005; 567: 445-457.
30. Feng MG, Navar LG. Angiotensin II-Mediated Constriction of Afferent and Efferent Arterioles Involves T-Type Ca Channel Activation. Am J Nephrol 2004; 24: 641-8.
31. Hayashi K, Ozawa Y, Wakino S, et al. Cellular mechanism for mibefradil-induced vasodilation of renal microcirculation: studies in the isolated perfused hydronephrotic kidney. J Cardiovasc Pharmacol 2003; 42: 697-702.
32. Gordienko DV, Clausen C, Goligorsky MS. Ionic currents and endothelin signaling in smooth muscle cells from rat renal resistance arteries. Am J Physiol 1994; 266: F325-F341.
33. Hall DA, Carmines PK, Sansom SC. Dihydropyridine-sensitive Ca(2+) channels in human glomerular mesangial cells. Am J Physiol Renal Physiol 2000; 278: F97-F103.
34. Ma R, Pluznick JL, Sansom SC. Ion channels in mesangial cells: function, malfunction, or fiction. Physiology (Bethesda) 2005; 20: 102-11.
35. Berra-Romani R, Blaustein MP, Matteson DR. TTX-sensitive voltage-gated Na+ channels are expressed in mesenteric artery smooth muscle cells. Am J Physiol Heart Circ Physiol 2005; 289: H137-H145.
36. Parekh AB. Store-operated Ca2+ entry: dynamic interplay between endoplasmic reticulum, mitochondria. and plasma membrane. J Physiol 2003; 547: 333-48.
37. Clapham DE. TRP channels as cellular sensors. Nature 2003; 426: 517-24.
38. Takenaka T, Suzuki H, Okada H, et al. Transient receptor potential channels in rat renal microcirculation: actions of angiotensin II. Kidney Int 2002; 62: 558-65.
39. Ma R, Smith S, Child A, et al. Store-operated Ca(2+) channels in human glomerular mesangial cells. Am J Physiol Renal Physiol 2000; 278: F954-F961.
40. Li WP, Tsiokas L, Sansom SC, et al. Epidermal growth factor activates store-operated Ca2+ channels through an inositol 1,4,5-trisphosphate-independent pathway in human glomerular mesangial cells. J Biol Chem 2004; 279: 4570-7.
41. Ma R, Sansom SC. Epidermal growth factor activates store-operated calcium channels in human glomerular mesangial cells. J Am Soc Nephrol 2001; 12: 47-53.
42. Ma R, Pluznick J, Kudlacek P, et al. Protein kinase C activates store-operated Ca(2+) channels in human glomerular mesangial cells. J Biol Chem 2001; 276: 25759-65.
43. Ma R, Kudlacek PE, Sansom SC. Protein kinase Calpha participates in activation of store-operated Ca2+ channels in human glomerular mesangial cells. Am J Physiol Cell Physiol 2002; 283: C1390-C1398.
44. Wang X, Pluznick JL, Wei P, et al. TRPC4 forms store-operated Ca2+ channels in mouse mesangial cells. Am J Physiol Cell Physiol 2004; 287: C357-C364.
45. Lee-Kwon W, Wade JB, Zhang Z, et al. Expression of TRPC4 channel protein that interacts with NHERF-2 in rat descending vasa recta. Am J Physiol Cell Physiol 2005; 288: C942-C949.
46. Kitamura K, Yamazaki J. Chloride channels and their functional roles in smooth muscle tone in the vasculature. Jpn J Pharmacol 2001; 85: 351-7.
47. Large WA, Wang Q. Characteristics and physiological role of the Ca(2+)-activated Cl-conductance in smooth muscle. Am J Physiol 1996; 271: C435-C454.
48. Hansen PB, Jensen BL, Skott O. Chloride regulates afferent arteriolar contraction in response to depolarization. Hypertension 1998; 32: 1066-70.
49. Jensen BL, Ellekvist P, Skott O. Chloride is essential for contraction of afferent arterioles after agonists and potassium. Am J Physiol 1997; 272: F389-F396.
50. Takenaka T, Kanno Y, Kitamura Y, et al. Role of chloride channels in afferent arteriolar constriction. Kidney Int 1996; 50: 864-72.
51. Carmines PK. Segment-specific effect of chloride channel blockade on rat renal arteriolar contractile responses to angiotensin II. Am J Hypertens 1995; 8: 90-4.
52. Pallone TL, Huang JM. Control of descending vasa recta pericyte membrane potential by angiotensin II. Am J Physiol Renal Physiol 2002; 282: F1064-F1074.
53. Pallone TL, Zhang Z, Rhinehart K. Physiology of the renal medullary microcirculation. Am J Physiol Renal Physiol 2003; 284: F253-F266.
54. Zhang Z, Huang JM, Turner MR, et al. Role of chloride in constriction of descending vasa recta by angiotensin II. Am J Physiol Regul Integr Comp Physiol 2001; 280: R1878-R1886.
55. Pallone TL, Cao C, Zhang Z. Inhibition of K+ conductance in descending vasa recta pericytes by ANG II. Am J Physiol Renal Physiol 2004; 287: F1213-F1222.
56. Hu S, Kim HS, Lappe RW, et al. Coupling of endothelin receptors to ion channels in rat glomerular mesangial cells. J Cardiovasc Pharmacol 1993; 22 Suppl 8: S149-S153.
57. Okuda T, Yamashita N, Kurokawa K. Angiotensin II and vasopressin stimulate calcium-activated chloride conductance in rat mesangial cells. J Clin Invest 1986; 78: 1443-8.
58. Steendahl J, Holstein-Rathlou NH, Sorensen CM, et al. Effects of chloride channel blockers on rat renal vascular responses to angiotensin II and norepinephrine. Am J Physiol Renal Physiol 2004; 286: F323-F330.
59. Nelson MT, Quayle JM. Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol 1995; 268: C799-C822.
60. Quayle JM, Nelson MT, Standen NB. ATP-sensitive and inwardly rectifying potassium channels in smooth muscle. Physiol Rev 1997; 77: 1165-232.
61. Busse R, Edwards G, Feletou M, et al. EDHF: bringing the concepts together. Trends Pharmacol Sci 2002; 23: 374-80.
62. Fleming I. Cytochrome P450 epoxygenases as EDHF synthase(s). Pharmacol Res 2004; 49: 525-33.
63. Popp R, Brandes RP, Ott G, et al. Dynamic modulation of interendothelial gap junctional communication by 11,12-epoxyeicosatrienoic acid. Circ Res 2002; 90: 800-6.
64. Quilley J, Fulton D, McGiff JC. Hyperpolarizing factors. Biochem Pharmacol 1997; 54: 1059-70.
65. Brayden JE. Functional roles of KATP channels in vascular smooth muscle. Clin Exp Pharmacol Physiol 2002; 29: 312-6.
66. Seino S, Miki T. Gene targeting approach to clarification of ion channel function: studies of Kir6.x null mice. J Physiol 2004; 554: 295-300.
67. Goto K, Fujii K, Onaka U, et al. Effects of adrenomedullin and PAMP on membrane potential and neurotransmission. Peptides 2000; 21: 257-63.
68. Kleppisch T, Nelson MT. Adenosine activates ATP-sensitive potassium channels in arterial myocytes via A2 receptors and cAMP-dependent protein kinase. Proc Natl Acad Sci USA 1995; 92: 12441-5.
69. Nelson MT, Huang Y, Brayden JE, et al. Arterial dilations in response to calcitonin gene-related peptide involve activation of K+ channels. Nature 1990; 344: 770-3.
70. Reslerova M, Loutzenhiser R. Renal microvascular actions of calcitonin gene-related peptide. Am J Physiol 1998; 274: F1078-F1085.
71. Standen NB, Quayle JM, Davies NW, et al. Hyperpolarizing vasodilators activate ATP-sensitive K+ channels in arterial smooth muscle. Science 1989; 245: 177-80.
72. Tang L, Parker M, Fei Q, et al. Afferent arteriolar adenosine A2a receptors are coupled to KATP in in vitro perfused hydronephrotic rat kidney. Am J Physiol 1999; 277: F926-F933.
73. Hayabuchi Y, Standen NB, Davies NW. Angiotensin II inhibits and alters kinetics of voltage-gated K(+) channels of rat arterial smooth muscle. Am J Physiol Heart Circ Physiol 2001; 281: H2480-H2489.
74. Miyoshi Y, Nakaya Y. Angiotensin II blocks ATP-sensitive K+ channels in porcine coronary artery smooth muscle cells. Biochem Biophys Res Commun 1991; 181: 700-6.
75. Miyoshi Y, Nakaya Y, Wakatsuki T, et al. Endothelin blocks ATP-sensitive K+ channels and depolarizes smooth muscle cells of porcine coronary artery. Circ Res 1992; 70: 612-6.
76. Thorneloe KS, Maruyama Y, Malcolm AT, et al. Protein kinase C modulation of recombinant ATT-sensitive K(+) channels composed of Kir6.1 and/or Kir6.2 expressed with SUR2B. J Physiol 2002; 541: 65-80.
77. Wakatsuki T, Nakaya Y, Miyoshi Y, et al. Effects of vasopressin on ATP-sensitive and Ca(2+)-activated K+ channels of coronary arterial smooth muscle cells. Jpn J Pharmacol 1992; 58 (Suppl 2): 339P.
78. Betts LC, Kozlowski RZ. Electrophysiological effects of endothelin-1 and their relationship to contraction in rat renal arterial smooth muscle. Br J Pharmacol 2000; 130: 787-96.
79. Fergus DJ, Martens JR, England SK. Kv channel subunits that contribute to voltage-gated K+ current in renal vascular smooth muscle. Pflugers Arch 2003; 445: 697-704.
80. Gebremedhin D, Kaldunski M, Jacobs ER, et al. Coexistence of two types of Ca(2+)-activated K+ channels in rat renal arterioles. Am J Physiol 1996; 270: F69-F81.
81. Prior HM, Yates MS, Beech DJ. Functions of large conductance Ca2+-activated (BKCa), delayed rectifier (KV) and background K+ channels in the control of membrane potential in rabbit renal arcuate artery. J Physiol 1998; 511 (Pt 1): 159-69.
82. Martens JR, Gelband CH. Alterations in rat interlobar artery membrane potential and K+ channels in genetic and nongenetic hypertension. Circ Res 1996; 79: 295-301.
83. Prior HM, Yates MS, Beech DJ. Role of K+ channels in A2A adenosine receptor-mediated dilation of the pressurized renal arcuate artery. Br J Pharmacol 1999; 126: 494-500.
84. Ma YH, Gebremedhin D, Schwartzman ML, et al. 20-Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries. Circ Res 1993; 72: 126-36.
85. Maier KG, Roman RJ. Cytochrome P450 metabolites of arachidonic acid in the control of renal function. Curr Opin Nephrol Hypertens 2001; 10: 81-7.
86. Zou AP, Fleming JT, Falck JR, et al. 20-HETE is an endogenous inhibitor of the large-conductance Ca(2+)-activated K+ channel in renal arterioles. Am J Physiol 1996; 270: R228-R237.
87. Sun CW, Falck JR, Harder DR, et al. Role of tyrosine kinase and PKC in the vasoconstrictor response to 20-HETE in renal arterioles. Hypertension 1999; 33: 414-8.
88. Sun CW, Alonso-Galicia M, Taheri MR, et al. Nitric oxide-20-hydroxyeicosatetraenoic acid interaction in the regulation of K+ channel activity and vascular tone in renal arterioles. Circ Res 1998; 83: 1069-79.
89. Kaide JI, Zhang F, Wei Y, et al. Carbon monoxide of vascular origin attenuates the sensitivity of renal arterial vessels to vasoconstrictors. J Clin Invest 2001; 107: 1163-71.
90. Imig JD. Eicosanoid regulation of the renal vasculature. Am J Physiol Renal Physiol 2000; 279: F965-F981.
91. Wang D, Borrego-Conde LJ, Falck JR, et al. Contributions of nitric oxide, EDHF, and EETs to endothelium-dependent relaxation in renal afferent arterioles. Kidney Int 2003; 63: 2187-93.
92. Zou AP, Fleming JT, Falck JR, et al. Stereospecific effects of epoxyeicosatrienoic acids on renal vascular tone and K(+)-channel activity. Am J Physiol 1996; 270: F822-F832.
93. Alonso-Galicia M, Sun CW, Falck JR, et al. Contribution of 20-HETE to the vasodilator actions of nitric oxide in renal arteries. Am J Physiol 1998; 275: F370-F378.
94. Li L, Wu J, Jiang C. Differential expression of Kir6.1 and SUR2B mRNAs in the vasculature of various tissues in rats. J Membr Biol 2003; 196: 61-9.
95. Sun X, Cao K, Yang G, et al. Selective expression of Kir6.1 protein in different vascular and non-vascular tissues. Biochem Pharmacol 2004; 67: 147-56.
96. Wang X, Trottier G, Loutzenhiser R. Determinants of renal afferent arteriolar actions of bradykinin: evidence that multiple pathways mediate responses attributed to EDHF. Am J Physiol Renal Physiol 2003; 285: F540-F549.
97. Chilton L, Loutzenhiser R. Functional evidence for an inward rectifier potassium current in rat renal afferent arterioles. Circ Res 2001; 88: 152-8.
98. Eckman DM, Nelson MT. Potassium ions as vasodilators: role of inward rectifier potassium channels. Circ Res 2001; 88: 132-3.
99. Leichtle A, Rauch U, Albinus M, et al. Electrophysiological and molecular characterization of the inward rectifier in juxtaglomerular cells from rat kidney. J Physiol 2004; 560: 365-76.
100. Fallet RW, Bast JP, Fujiwara K, et al. Influence of Ca(2+)-activated K(+) channels on rat renal arteriolar responses to depolarizing agonists. Am J Physiol Renal Physiol 2001; 280: F583-F591.
101. Kirton CA, Loutzenhiser R. Alterations in basal protein kinase C activity modulate renal afferent arteriolar myogenic reactivity. Am J Physiol 1998; 275: H467-H475.
102. Loutzenhiser RD, Parker MJ. Hypoxia inhibits myogenic reactivity of renal afferent arterioles by activating ATP-sensitive K+ channels. Circ Res 1994; 74: 861-9.
103. Reslerova M, Loutzenhiser R. Divergent mechanisms of ATP-sensitive K+ channel-induced vasodilation in renal afferent and efferent arterioles. Evidence of L-type Ca2+ channel-dependent and -independent actions of pinacidil. Circ Res 1995; 77: 1114-20.
104. Russ U, Rauch U, Quast U. Pharmacological evidence for a KATP channel in renin-secreting cells from rat kidney. J Physiol 1999; 517 (Pt 3): 781-90.
105. Metzger F, Quast U. Binding of [3H]-P1075, an opener of ATP-sensitive K+ channels, to rat glomerular preparations. Naunyn Schmiedebergs Arch Pharmacol 1996; 354: 452-9.
106. Zhang Z, Rhinehart K, Pallone TL. Membrane potential controls calcium entry into descending vasa recta pericytes. Am J Physiol Regul Integr Comp Physiol 2002; 283: R949-R957.
107. Cao C, Lee-Kwon W, Silldorff EP, et al. KATP Channel Conductance of Descending Vasa Recta Pericytes. Am J Physiol Renal Physiol 2005; 289: F1235-F1245.
108. Marchetti J, Praddaude F, Rajerison R, et al. Bradykinin attenuates the [Ca(2+)](i) response to angiotensin II of renal juxtamedullary efferent arterioles via an EDHF. Br J Pharmacol 2001; 132: 749-59.
109. Brezis M, Rosen S. Hypoxia of the renal medulla-its implications for disease. N Engl J Med 1995; 332: 647-55.
110. Brezis M, Heyman SN, Dinour D, et al. Role of nitric oxide in renal medullary oxygenation. Studies in isolated and intact rat kidneys. J Clin Invest 1991; 88: 390-5.
111. Parekh N, Zoo AP. Role of prostaglandins in renal medullary circulation: response to different vasoconstrictors. Am J Physiol 1996; 271: F653-17658.
112. Sadowski J, Kompanowska-Jezierska E, Dobrowolski L et al. Simultaneous recording of tissue ion content and blood flow in rat renal medulla: evidence on interdependence. Am J Physiol 1997; 273: F658-F662.
113. Stockand JD, Sansom SC. Glomerular mesangial cells: electrophysiology and regulation of contraction. Physiol Rev 1998; 78: 723-44.
114. Barber RD, Woolf AS, Henderson RM. Potassium conductances and proliferation in conditionally immortalized renal glomerular mesangial cells from the H-2Kb-tsA58 transgenic mouse. Biochim Biophys Acta 1997; 1355: 191-203.
115. Szamosfalvi B, Cortes P, Alviani R, et al. Putative subunits of the rat mesangial KATP: a type 2B sulfonylurea receptor and an inwardly rectifying K+ channel. Kidney Int 2002; 61: 1739-49.
116. Stockand JD, Sansom SC. Activation by methylene blue of large Ca(2+)-activated K+ channels. Biochim Biophys Acta 1996; 1285: 123-6.
117. Stockand JD, Sansom SC. Role of large Ca(2+)-activated K+ channels in regulation of mesangial contraction by nitroprusside and ANP. Am J Physiol 1996; 270: C1773-C1779.
118. Matsunaga H, Yamashita N, Miyajima Y, et al. Ion channel activities of cultured rat mesangial cells. Am J Physiol 1991; 261: F808-F814.
119. Sansom SC, Stockand JD. Physiological role of large, Ca2+-activated K+ channels in human glomerular mesangial cells. Clin Exp Pharmacol Physiol 1996; 23: 76-82.
120. Stockand JD, Sansom SC. Large Ca(2+)-activated K+ channels responsive to angiotensin II in cultured human mesangial cells. Am J Physiol 1994; 267: C1080-C1086.
121. Stockand JD, Silverman M, Hall D, et al. Arachidonic acid potentiates the feedback response of mesangial BKCa channels to angiotensin II. Am J Physiol 1998; 274: F658-F664.
122. Sansom SC, Ma R, Carmines PK, et al. Regulation of Ca(2+)-activated K(+) channels by multifunctional Ca(2+)/calmodulin-dependent protein kinase. Am J Physiol Renal Physiol 2000; 279: F283-F288.
123. Cermak R, Kleta R, Forssmann WG, et al. Natriuretic peptides increase a K+ conductance in rat mesangial cells. Pflugers Arch 1996; 431: 571-7.
124. Kudlacek PE, Pluznick JL, Ma R, et al. Role of hbeta1 in activation of human mesangial BK channels by cGMP kinase. Am J Physiol Renal Physiol 2003; 285: F289-F294.
125. Sansom SC, Stockand JD, Hall D, et al. Regulation of large calcium-activated potassium channels by protein phosphatase 2A. J Biol Chem 1997; 272: 9902-6.
126. Dhein S. Peptides acting at gap junctions. Peptides 2002; 23: 1701-9.
127. De Wit C. Connexins pave the way for vascular communication. News Physiol Sci 2004; 19: 148-53.
128. Evans WH, Martin PE. Gap junctions: structure and function (Review). Mol Membr Biol 2002; 19: 121-36.
129. Figueroa XF, Isakson BE, Duling BR. Connexins: gaps in our knowledge of vascular function. Physiology (Bethesda) 2004; 19: 277-84.
130. De Wit C, Roos F, Bolz SS, et al. Lack of vascular connexin 40 is associated with hypertension and irregular arteriolar vasomotion. Physiol Genomics 2003; 13: 169-77.
131. De Wit C, Roos F, Bolz SS, et al. Impaired conduction of vasodilation along arterioles in connexin40-deficient mice. Circ Res 2000; 86: 649-55.
132. Figueroa XF, Paul DL, Simon AM, et al. Central role of connexin40 in the propagation of electrically activated vasodilation in mouse cremasteric arterioles in vivo. Circ Res 2003; 92: 793-800.
133. Liao Y, Day KH, Damon DN, et al. Endothelial cell-specific knockout of connexin 43 causes hypotension and bradycardia in mice. Proc Natl Acad Sci USA 2001; 98: 9989-94.
134. Earley S, Resta TC, Walker BR. Disruption of smooth muscle gap junctions attenuates myogenic vasoconstriction of mesenteric resistance arteries. Am J Physiol Heart Circ Physiol 2004; 287: H2677-H2686.
135. Hwan SK, Beyer EC. Heterogeneous localization of connexin40 in the renal vasculature. Microvasc Res 2000; 59: 140-8.
136. Mink D, Schiller A, Kriz W, et al. Interendothelial junctions in kidney vessels. Cell Tissue Res 1984; 236: 567-76.
137. Silverstein DM, Thornhill BA, Leung JC, et al. Expression of connexins in the normal and obstructed developing kidney. Pediatr Nephrol 2003; 18: 216-24.
138. Karagiannis J, Rand M, Li CG. Role of gap junctions in endothelium-derivedhyperpolarizing factor-mediated vasodilatation in rat renal artery. Acta Pharmacol Sin 2004; 25: 1031-7.
139. Udosen IT, Jiang H, Hercule HC, et al. Nitric oxide-epoxygenase interactions and arachidonate-induced dilation of rat renal microvessels. Am J Physiol Heart Circ Physiol 2003; 285: H2054-H2063.
140. Salomonsson M, Gustafsson F, Andreasen D, et al. Local electric stimulation causes conducted calcium response in rat interlobular arteries. Am J Physiol Renal Physiol 2002; 283: F473-F480.
141. Levick JR. An Introduction to Cardiovascular Physiology. London: Arnold, 2003.
142. Staessen JA, Wang J, Bianchi G, et al. Essential hypertension. Lancet 2003; 361: 1629-41.
143. Crowley SD, Gurley SB, Oliverio MI, et al. Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system. J Clin Invest 2005; 115: 1092-9.
144. Mattson DL. Importance of the renal medullary circulation in the control of sodium excretion and blood pressure. Am J Physiol Regul Integr Comp Physiol 2003; 284: R13-R27.
145. Cox RH, Rusch NJ. New expression profiles of voltage-gated ion channels in arteries exposed to high blood pressure. Microcirculation 2002; 9: 243-57.
146. Ohya Y, Tsuchihashi T, Kagiyama S, et al. Single L-type calcium channels in smooth muscle cells from resistance arteries of spontaneously hypertensive rats. Hypertension 1998; 31: 1125-9.
147. Fellner SK, Arendshorst WJ. Store-operated Ca2+ entry is exaggerated in fresh preglomerular vascular smooth muscle cells of SHR. Kidney Int 2002; 61: 2132-41.
148. Pesic A, Madden JA, Pesic K et al. High blood pressure upregulates arterial L-type Ca2+ channels: is membrane depolarization the signal? Circ Res 2004; 94: e97-104.
149. Hill MA, Zou H, Potocnik SJ, et al. Invited review: arteriolar smooth muscle mechanotransduction: Ca(2+) signaling pathways underlying myogenic reactivity. J Appl Physiol 2001; 91: 973-83.
150. Fellner SK, Arendshorst WJ. Capacitative calcium entry in smooth muscle cells from preglomerular vessels. Am J Physiol 1999; 277: F533-F542.
151. Minke B, Cook B. TRP channel proteins and signal transduction. Physiol Rev 2002; 82: 429-72.
152. Feng JJ, Arendshorst WJ. Enhanced renal vasoconstriction induced by vasopressin in SHR is mediated by V1 receptors. Am J Physiol 1996; 271: F304-F313.
153. Salomonsson M, Arendshorst WJ. Norepinephrine-induced calcium signaling pathways in afferent arterioles of genetically hypertensive rats. Am J Physiol Renal Physiol 2001; 281: F264-F272.
154. Imig JD, Inscho EW. Adaptations of the renal microcirculation to hypertension. Microcirculation 2002; 9: 315-28.
155. Golovina VA, Platoshyn O, Bailey CL, et al. Upregulated TRP and enhanced capacitative Ca(2+) entry in human pulmonary artery myocytes during proliferation. Am J Physiol Heart Circ Physiol 2001; 280: H746-H755.
156. Carmines PK, Ohishi K, Ikenaga H. Functional impairment of renal afferent arteriolar voltage-gated calcium channels in rats with diabetes mellitus. J Clin Invest 1996; 98: 2564-71.
157. Ortiz PA, Garvin JL. Intrarenal transport and vasoactive substances in hypertension. Hypertension 2001; 38: 621-4.
158. Sobey CG. Potassium channel function in vascular disease. Arterioscler Thromb Vasc Biol 2001; 21: 28-38.
159. Jackson WF. Ion channels and vascular tone. Hypertension 2000; 35: 173-8.
160. Haefliger JA, Demotz S, Braissant O, et al. Connexins 40 and 43 are differentially regulated within the kidneys of rats with renovascular hypertension. Kidney Int 2001; 60: 190-201.
161. Haefliger JA, Nicod P, Meda P. Contribution of connexins to the function of the vascular wall. Cardiovasc Res 2004; 62: 345-56.
162. De Vriese AS, Van D, V, Lameire NH. Effects of connexin-mimetic peptides on nitric oxide synthase- and cyclooxygenase-independent renal vasodilation. Kidney Int 2002; 61: 177-85.
163. Rummery NM, Hill CE. Vascular gap junctions and implications for hypertension. Clin Exp Pharmacol Physiol 2004; 31: 659-67.
164. Zhao X, Imig JD. Kidney CYP450 enzymes: biological actions beyond drug metabolism. Curr Drug Metab 2003; 4: 73-84.
165. Roman RJ. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 2002; 82: 131-85.
166. Natarajan R, Reddy MA. HETEs/EETs in renal glomerular and epithelial cell functions. Curr Opin Pharmacol 2003; 3: 198-203.
167. Sarkis A, Roman RJ. Role of cytochrome P450 metabolites of arachidonic acid in hypertension. Curr Drug Metab 2004; 5: 245-56.
168. Imig JD, Pham BT, LeBlanc EA, et al. Cytochrome P450 and cyclooxygenase metabolites contribute to the endothelin-1 afferent arteriolar vasoconstrictor and calcium responses. Hypertension 2000; 35: 307-12.
169. Kaide J, Wang MH, Wang JS, et al. Transfection of CYP4A1 cDNA increases vascular reactivity in renal interlobar arteries. Am J Physiol Renal Physiol 2003; 284: F51-F56.
170. Moreno C, Maier KG, Hoagland KM, et al. Abnormal pressure-natriuresis in hypertension: role of cytochrome P450 metabolites of arachidonic acid. Am J Hypertens 2001; 14: 90S-7S.
171. Fleming I. Cytochrome P-450 under pressure: more evidence for a link between 20-hydroxyeicosatetraenoic acid and hypertension. Circulation 2005; 111: 5-7.
172. Zhang Z, Rhinehart K, Pallone TL. Membrane potential controls calcium entry into descending vasa recta pericytes. Am J Physiol Regul Integr Comp Physiol 2002; 283: R949-R957.